By activating ADOR signaling pathways, ADO suppresses tumor antigen presentation, T cell activation and infiltration, and cytotoxic T lymphocyte-mediated tumor cell killing, thereby exerting immunosuppressive effects and promoting tumor immune evasion. This evidence concerns the gene ADO and neoplasm.